Genomtec S.A.
GMT.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| % Growth | 0% | -97.5% | -81.7% | – |
| Cost of Goods Sold | PLN 2 | PLN 1 | PLN 1 | PLN 1 |
| Gross Profit | PLN 0 | -PLN 1 | -PLN 1 | -PLN 0 |
| % Margin | 100% | -79,300% | -2,042.5% | -171.7% |
| R&D Expenses | PLN 4 | PLN 1 | PLN 3 | PLN 5 |
| G&A Expenses | PLN 4 | PLN 9 | PLN 9 | PLN 5 |
| SG&A Expenses | PLN 4 | PLN 9 | PLN 8 | PLN 5 |
| Sales & Mktg Exp. | PLN 0 | PLN 0 | -PLN 1 | PLN 0 |
| Other Operating Expenses | PLN 3 | -PLN 2 | PLN 0 | PLN 0 |
| Operating Expenses | PLN 11 | PLN 8 | PLN 11 | PLN 10 |
| Operating Income | -PLN 11 | -PLN 9 | -PLN 12 | -PLN 11 |
| % Margin | -1,105,500% | -872,700% | -29,882.5% | -4,812.8% |
| Other Income/Exp. Net | -PLN 0 | -PLN 0 | PLN 0 | -PLN 0 |
| Pre-Tax Income | -PLN 11 | -PLN 9 | -PLN 12 | -PLN 7 |
| Tax Expense | PLN 0 | -PLN 0 | PLN 0 | PLN 0 |
| Net Income | -PLN 11 | -PLN 9 | -PLN 12 | -PLN 7 |
| % Margin | -1,120,800% | -901,300% | -29,820% | -3,248.9% |
| EPS | -0.84 | -0.74 | -1.27 | -0.87 |
| % Growth | -13.5% | 41.7% | -46% | – |
| EPS Diluted | -0.84 | -0.74 | -1.27 | -0.87 |
| Weighted Avg Shares Out | 13 | 12 | 9 | 8 |
| Weighted Avg Shares Out Dil | 13 | 12 | 9 | 8 |
| Supplemental Information | – | – | – | – |
| Interest Income | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Interest Expense | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Depreciation & Amortization | PLN 2 | PLN 1 | PLN 0 | PLN 1 |
| EBITDA | -PLN 9 | -PLN 8 | -PLN 11 | -PLN 7 |
| % Margin | -872,500% | -775,600% | -27,640% | -3,003.7% |